Albiglutide
Safety and Efficacy Study of Albiglutide in Type 2 Diabetes
GSK · Phase 3 · Completed · Enrollment 309
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| albiglutide | T2D only | n/r | 12 | n/r | n/r |
| placebo | T2D only | n/r | 12 | n/r | n/r |
| albiglutide up-titration | T2D only | n/r | 12 | n/r | n/r |